Results for 'Khurram Shahzad'

Order:
  1. Organizational Justice and Job Outcomes: Moderating Role of Islamic Work Ethic.Khurram Khan, Muhammad Abbas, Asma Gul & Usman Raja - 2015 - Journal of Business Ethics 126 (2):1-12.
    Using a time-lagged design, we tested the main effects of Islamic Work Ethic (IWE) and perceived organizational justice on turnover intentions, job satisfaction, and job involvement. We also investigated the moderating influence of IWE in justice–outcomes relationship. Analyses using data collected from 182 employees revealed that IWE was positively related to satisfaction and involvement and negatively related to turnover intentions. Distributive fairness was negatively related to turnover intentions, whereas procedural justice was positively related to satisfaction. In addition, procedural justice was (...)
    Download  
     
    Export citation  
     
    Bookmark   20 citations  
  2. Investigating the Psychology of Financial Markets During COVID-19 Era: A Case Study of the US and European Markets.Khurram Shehzad, Liu Xiaoxing, Muhammad Arif, Khaliq Ur Rehman & Muhammad Ilyas - 2020 - Frontiers in Psychology 11:1-13.
    The novel coronavirus (COVID-19) has imperatively shaken the behavior of the global financial markets. This study estimated the impact of COVID-19 on the behavior of the financial markets of Europe and the US. The results revealed that the returns of the S&P 500 index have been greatly affected by a lockdown in the US owing to COVID-19. However, the health crisis generated due to the novel coronavirus significantly decreased the stock returns of the Nasdaq Composite index. The results also showed (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  3. PROTACs: The Future of Leukemia Therapeutics.Zubair Anwar, Muhammad Shahzad Ali, Antonio Galvano, Alessandro Perez, Maria La Mantia, Ihtisham Bukhari & Bartlomiej Swiatczak - 2022 - Frontiers in Cell and Developmental Biology 10:851087.
    The fight to find effective, long-lasting treatments for cancer has led many researchers to consider protein degrading entities. Recent developments in PROteolysis TArgeting Chimeras (PROTACs) have signified their potential as possible cancer therapies. PROTACs are small molecule, protein degraders that function by hijacking the built-in Ubiquitin-Proteasome pathway. This review mainly focuses on the general design and functioning of PROTACs as well as current advancements in the development of PROTACs as anticancer therapies. Particular emphasis is given to PROTACs designed against various (...)
    Download  
     
    Export citation  
     
    Bookmark